Voyager: Alzheimer’s Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis (VYGR)

Date:


Neurons and Microglia

koto_feja/E+ via Getty Images

Thesis

Voyager Therapeutics, Inc. (NASDAQ:VYGR) is a biotechnology company in the clinical stage, which is focused on developing novel therapies, mostly gene-based therapies, for the treatment of conditions that alter the nervous system such as Alzheimer’s disease (AD), amyotrophic



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related